期刊
CANCER CELL INTERNATIONAL
卷 13, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1475-2867-13-23
关键词
C-Myc; Hepatic cancer; HepG(2) cells; RNAi; siRNA
类别
资金
- National Natural Science Foundation of China [30872510, 81200320, 81272534, 81260349]
- Natural Science Foundation of Hubei Province [2008CDB127]
- Natural Science Foundation of Shanghai [064119620, 10411968400]
- Health System Key Discipline Group of Pudong New District [PWZXKQ2010-5]
- Foundation of Shanghai Tenth People Hospital [12XSGG105]
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Although much is known about both the cellular changes that lead to HCC and the etiological agents responsible for the majority of HCC cases, the molecule pathogenesis of HCC is still not well understood. We aimed to determine the effect of c-Myc gene expression on the proliferative, invasive, and migrative capabilities of hepatocellular carcinoma HepG(2) cells. Methods: A plasmid-based polymerase III promoter system was used to deliver and express short interfering RNA targeting c-Myc to reduce its expression in HepG(2) cells. Western blot analysis was used to measure the protein level of c-Myc in HepG(2) cells. The effects of c-Myc silencing on the invasion, motility, and proliferation of HepG(2) cells were assessed using a Transwell chamber cell migration assay system and a growth curve assay, respectively. Results: The data showed that plasmids expressing siRNA against c-Myc significantly decreased its expression in HepG(2) cells by up to 85%. Importantly, pSilencer-c-Myc transfected cells showed a significantly reduced potential in migration, invasion, and proliferation. Conclusion: C-Myc plays an important role in the development of hepatocellular carcinoma. The data show that down-regulating the c-Myc protein level in HepG(2) cells by RNAi could significantly inhibit migration, invasion and proliferation of HepG(2) cells. Thus, c-Myc might be a potential therapeutic target for hepatocellular carcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据